NCT06300710 is a clinical trial in Cardio Respiratory Arrest, sponsored by Assiut University.

Who is sponsoring NCT06300710?

NCT06300710 is sponsored by Assiut University.

What condition does NCT06300710 study?

NCT06300710 studies Cardio Respiratory Arrest.

Is NCT06300710 still recruiting?

NCT06300710 is currently status unknown. Last updated 30 July 2024.

Last reviewed 2024-07-30 · How we verify

NCT06300710

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcomes and Risk Factors of CPR in PICU

Status unknown Last updated 30 July 2024

What this trial tests

trial in Cardio Respiratory Arrest in 30 participants. Status unknown.

Timeline

1 August 2024

Primary endpoint
1 February 2025

1 March 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 August 2024
Primary completion	1 February 2025
Estimated completion	1 March 2025

Conditions studied

Cardio Respiratory Arrest — all drugs for Cardio Respiratory Arrest →

Sponsor

Assiut University

Who can join

Adults 1 Month to 18, any sex, with Cardio Respiratory Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. To detect the frequency and the underlying causes of cardiopulmonary arrest . 2. To detect outcome of CPR 3. To identify the associated risk factors for the different outcomes after CPR among those patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06300710 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 30 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06300710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing